Showing results (21-30 of 89) with videos related to
Sort By:
Pageof 9
BMC Cancer|October 17, 2015
Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survivalAminah Jatoi, Nathan R Foster, Kimberly R Kalli, et al.Journal of Cachexia, Sarcopenia and Muscle|September 17, 2020
Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patientsJennifer Le-Rademacher, Camden Lopez, Eric Wolfe, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 23, 2013
Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literatureKrishna Patel, Nathan R Foster, Ann Farrell, et al.American Journal of Clinical Oncology|October 20, 2025
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian CancerAminah Jatoi, Nathan R Foster, Andrea Wahner Hendrickson, et al.Journal of Gastrointestinal Cancer|November 22, 2008
Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943Steven R Alberts, Jonathan R Sande, Nathan R Foster, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancerEvanthia Galanis, Stephanie K Carlson, Nathan R Foster, et al.Cancer|November 10, 2023
A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104)Alan L Ho, Nathan R Foster, Shyamprasad Deraje Vasudeva, et al.Oral Oncology|January 29, 2021
A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101Michael J Jelinek, Nathan R Foster, Alex J Zoroufy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancerAmy J French, Daniel J Sargent, Lawrence J Burgart, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trialsFrank A Sinicrope, Nathan R Foster, Harry H Yoon, et al.Pageof 9